Scalise CB - Search Results

1

A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment.

Scalise CB, Kincaid K, Thigpen H, Moore J, Dover B, Norian L, Meza-Perez S, Randall T, Birrer M, Odunsi K, Arend RC. Scalise CB, et al. Gynecol Oncol. 2024 Jun;185:83-94. doi: 10.1016/j.ygyno.2024.02.008. Epub 2024 Feb 20. Gynecol Oncol. 2024. PMID: 38377762

2

Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy.

Wall JA, Meza-Perez S, Scalise CB, Katre A, Londoño AI, Turbitt WJ, Randall T, Norian LA, Arend RC. Wall JA, et al. Among authors: scalise cb. Gynecol Oncol. 2021 Jan;160(1):285-294. doi: 10.1016/j.ygyno.2020.10.031. Epub 2020 Nov 7. Gynecol Oncol. 2021. PMID: 33168307 Free PMC article.

3

Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.

Dholakia J, Scalise CB, Katre AA, Goldsberry WN, Meza-Perez S, Randall TD, Norian LA, Novak L, Arend RC. Dholakia J, et al. Among authors: scalise cb. Gynecol Oncol. 2022 Jan;164(1):170-180. doi: 10.1016/j.ygyno.2021.09.026. Epub 2021 Nov 26. Gynecol Oncol. 2022. PMID: 34844776 Free PMC article.

4

Understanding the effect of mechanical forces on ovarian cancer progression.

Martinez A, Buckley M, Scalise CB, Katre AA, Dholakia JJ, Crossman D, Birrer MJ, Berry JL, Arend RC. Martinez A, et al. Among authors: scalise cb. Gynecol Oncol. 2021 Jul;162(1):154-162. doi: 10.1016/j.ygyno.2021.04.003. Epub 2021 Apr 20. Gynecol Oncol. 2021. PMID: 33888338 Free PMC article.

5

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies.

Dholakia J, Scalise C, Arend RC. Dholakia J, et al. Cancers (Basel). 2021 Apr 2;13(7):1694. doi: 10.3390/cancers13071694. Cancers (Basel). 2021. PMID: 33918476 Free PMC article. Review.

6

Metabolic Alterations and WNT Signaling Impact Immune Response in HGSOC.

Arend RC, Scalise CB, Gordon ER, Davis AM, Foxall ME, Johnston BE, Crossman DK, Cooper SJ. Arend RC, et al. Among authors: scalise cb. Clin Cancer Res. 2022 Apr 1;28(7):1433-1445. doi: 10.1158/1078-0432.CCR-21-2984. Clin Cancer Res. 2022. PMID: 35031546 Free PMC article.

7

High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile.

Kako TD, Kamal MZ, Dholakia J, Scalise CB, Arend RC. Kako TD, et al. Among authors: scalise cb. Int J Clin Oncol. 2022 Feb;27(2):323-331. doi: 10.1007/s10147-021-02089-2. Epub 2022 Jan 17. Int J Clin Oncol. 2022. PMID: 35038071 Review.

8

Response to anti-DKK1 therapy in uterine carcinosarcoma: A case report.

ElNaggar A, Zhang N, Scalise CB, Sirard C, Kagey MH, Vaena D, Arend R. ElNaggar A, et al. Among authors: scalise cb. Gynecol Oncol Rep. 2021 Dec 9;39:100904. doi: 10.1016/j.gore.2021.100904. eCollection 2022 Feb. Gynecol Oncol Rep. 2021. PMID: 35531363 Free PMC article.

9

Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance.

Goel N, Foxall ME, Scalise CB, Wall JA, Arend RC. Goel N, et al. Among authors: scalise cb. Mol Cancer Ther. 2021 Sep;20(9):1542-1549. doi: 10.1158/1535-7163.MCT-20-0992. Epub 2021 Jun 25. Mol Cancer Ther. 2021. PMID: 34172532 Free PMC article. Review.

10

Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer.

Arend RC, Scalise CB, Dholakia J, Kamal MZ, Thigpen HB, Crossman D, Huh WK, Leath CA 3rd. Arend RC, et al. Among authors: scalise cb. Cancer Med. 2021 Nov;10(22):8238-8250. doi: 10.1002/cam4.4247. Epub 2021 Nov 2. Cancer Med. 2021. PMID: 34729947 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters